866-997-4948(US-Canada Toll Free)

Global Engineered T Cells Sales Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 113 Pages

This report studies the global Engineered T Cells market status and forecast, categorizes the global Engineered T Cells market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Engineered T Cells market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Cancer Research Centers
Clinics

The study objectives of this report are:
To analyze and study the global Engineered T Cells sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Engineered T Cells players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Engineered T Cells are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Engineered T Cells Manufacturers
Engineered T Cells Distributors/Traders/Wholesalers
Engineered T Cells Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Engineered T Cells market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Engineered T Cells Sales Market Report 2018
1 Engineered T Cells Market Overview
1.1 Product Overview and Scope of Engineered T Cells
1.2 Classification of Engineered T Cells by Product Category
1.2.1 Global Engineered T Cells Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Engineered T Cells Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Tumor Infiltrating Lymphocytes
1.2.4 T Cell Receptor {TCR}
1.2.5 Chimeric Antigen Receptor (CAR)
1.3 Global Engineered T Cells Market by Application/End Users
1.3.1 Global Engineered T Cells Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospitals
1.3.2 Cancer Research Centers
1.3.3 Clinics
1.4 Global Engineered T Cells Market by Region
1.4.1 Global Engineered T Cells Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Engineered T Cells Status and Prospect (2013-2025)
1.4.3 Europe Engineered T Cells Status and Prospect (2013-2025)
1.4.4 China Engineered T Cells Status and Prospect (2013-2025)
1.4.5 Japan Engineered T Cells Status and Prospect (2013-2025)
1.4.6 Southeast Asia Engineered T Cells Status and Prospect (2013-2025)
1.4.7 India Engineered T Cells Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Engineered T Cells (2013-2025)
1.5.1 Global Engineered T Cells Sales and Growth Rate (2013-2025)
1.5.2 Global Engineered T Cells Revenue and Growth Rate (2013-2025)

2 Global Engineered T Cells Competition by Players/Suppliers, Type and Application
2.1 Global Engineered T Cells Market Competition by Players/Suppliers
2.1.1 Global Engineered T Cells Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Engineered T Cells Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Engineered T Cells (Volume and Value) by Type
2.2.1 Global Engineered T Cells Sales and Market Share by Type (2013-2018)
2.2.2 Global Engineered T Cells Revenue and Market Share by Type (2013-2018)
2.3 Global Engineered T Cells (Volume and Value) by Region
2.3.1 Global Engineered T Cells Sales and Market Share by Region (2013-2018)
2.3.2 Global Engineered T Cells Revenue and Market Share by Region (2013-2018)
2.4 Global Engineered T Cells (Volume) by Application

3 United States Engineered T Cells (Volume, Value and Sales Price)
3.1 United States Engineered T Cells Sales and Value (2013-2018)
3.1.1 United States Engineered T Cells Sales and Growth Rate (2013-2018)
3.1.2 United States Engineered T Cells Revenue and Growth Rate (2013-2018)
3.1.3 United States Engineered T Cells Sales Price Trend (2013-2018)
3.2 United States Engineered T Cells Sales Volume and Market Share by Players (2013-2018)
3.3 United States Engineered T Cells Sales Volume and Market Share by Type (2013-2018)
3.4 United States Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

4 Europe Engineered T Cells (Volume, Value and Sales Price)
4.1 Europe Engineered T Cells Sales and Value (2013-2018)
4.1.1 Europe Engineered T Cells Sales and Growth Rate (2013-2018)
4.1.2 Europe Engineered T Cells Revenue and Growth Rate (2013-2018)
4.1.3 Europe Engineered T Cells Sales Price Trend (2013-2018)
4.2 Europe Engineered T Cells Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Engineered T Cells Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

5 China Engineered T Cells (Volume, Value and Sales Price)
5.1 China Engineered T Cells Sales and Value (2013-2018)
5.1.1 China Engineered T Cells Sales and Growth Rate (2013-2018)
5.1.2 China Engineered T Cells Revenue and Growth Rate (2013-2018)
5.1.3 China Engineered T Cells Sales Price Trend (2013-2018)
5.2 China Engineered T Cells Sales Volume and Market Share by Players (2013-2018)
5.3 China Engineered T Cells Sales Volume and Market Share by Type (2013-2018)
5.4 China Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

6 Japan Engineered T Cells (Volume, Value and Sales Price)
6.1 Japan Engineered T Cells Sales and Value (2013-2018)
6.1.1 Japan Engineered T Cells Sales and Growth Rate (2013-2018)
6.1.2 Japan Engineered T Cells Revenue and Growth Rate (2013-2018)
6.1.3 Japan Engineered T Cells Sales Price Trend (2013-2018)
6.2 Japan Engineered T Cells Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Engineered T Cells Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Engineered T Cells (Volume, Value and Sales Price)
7.1 Southeast Asia Engineered T Cells Sales and Value (2013-2018)
7.1.1 Southeast Asia Engineered T Cells Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Engineered T Cells Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Engineered T Cells Sales Price Trend (2013-2018)
7.2 Southeast Asia Engineered T Cells Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Engineered T Cells Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

8 India Engineered T Cells (Volume, Value and Sales Price)
8.1 India Engineered T Cells Sales and Value (2013-2018)
8.1.1 India Engineered T Cells Sales and Growth Rate (2013-2018)
8.1.2 India Engineered T Cells Revenue and Growth Rate (2013-2018)
8.1.3 India Engineered T Cells Sales Price Trend (2013-2018)
8.2 India Engineered T Cells Sales Volume and Market Share by Players (2013-2018)
8.3 India Engineered T Cells Sales Volume and Market Share by Type (2013-2018)
8.4 India Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

9 Global Engineered T Cells Players/Suppliers Profiles and Sales Data
9.1 Autolus Limited
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Engineered T Cells Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Autolus Limited Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Bellicum Pharmaceuticals
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Engineered T Cells Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Cells Medica
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Engineered T Cells Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Cells Medica Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Elli Lilly and Company
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Engineered T Cells Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Gilead Sciences
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Engineered T Cells Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Gilead Sciences Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Juno Therapeutics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Engineered T Cells Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Novartis
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Engineered T Cells Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novartis Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Oxford Biomedica
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Engineered T Cells Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Engineered T Cells Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pfizer Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Precision Bioscience
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Engineered T Cells Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Precision Bioscience Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Redmile Group
9.12 Seeking Alpha
9.13 Unum Therapeutics

10 Engineered T Cells Maufacturing Cost Analysis
10.1 Engineered T Cells Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Engineered T Cells
10.3 Manufacturing Process Analysis of Engineered T Cells

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Engineered T Cells Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Engineered T Cells Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Engineered T Cells Market Forecast (2018-2025)
14.1 Global Engineered T Cells Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Engineered T Cells Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Engineered T Cells Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Engineered T Cells Price and Trend Forecast (2018-2025)
14.2 Global Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Engineered T Cells Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Engineered T Cells Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Engineered T Cells Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Engineered T Cells Sales Forecast by Type (2018-2025)
14.3.2 Global Engineered T Cells Revenue Forecast by Type (2018-2025)
14.3.3 Global Engineered T Cells Price Forecast by Type (2018-2025)
14.4 Global Engineered T Cells Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Engineered T Cells
Figure Global Engineered T Cells Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Engineered T Cells Sales Volume Market Share by Type (Product Category) in 2017
Figure Tumor Infiltrating Lymphocytes Product Picture
Figure T Cell Receptor {TCR} Product Picture
Figure Chimeric Antigen Receptor (CAR) Product Picture
Figure Global Engineered T Cells Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Engineered T Cells by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Cancer Research Centers Examples
Table Key Downstream Customer in Cancer Research Centers
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Global Engineered T Cells Market Size (Million USD) by Regions (2013-2025)
Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Engineered T Cells Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Engineered T Cells Sales Volume (K Units) (2013-2018)
Table Global Engineered T Cells Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Engineered T Cells Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Engineered T Cells Sales Share by Players/Suppliers
Figure 2017 Engineered T Cells Sales Share by Players/Suppliers
Figure Global Engineered T Cells Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Engineered T Cells Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Engineered T Cells Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Engineered T Cells Revenue Share by Players
Table 2017 Global Engineered T Cells Revenue Share by Players
Table Global Engineered T Cells Sales (K Units) and Market Share by Type (2013-2018)
Table Global Engineered T Cells Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Engineered T Cells by Type (2013-2018)
Figure Global Engineered T Cells Sales Growth Rate by Type (2013-2018)
Table Global Engineered T Cells Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Engineered T Cells Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Engineered T Cells by Type (2013-2018)
Figure Global Engineered T Cells Revenue Growth Rate by Type (2013-2018)
Table Global Engineered T Cells Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Engineered T Cells Sales Share by Region (2013-2018)
Figure Sales Market Share of Engineered T Cells by Region (2013-2018)
Figure Global Engineered T Cells Sales Growth Rate by Region in 2017
Table Global Engineered T Cells Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Engineered T Cells Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Engineered T Cells by Region (2013-2018)
Figure Global Engineered T Cells Revenue Growth Rate by Region in 2017
Table Global Engineered T Cells Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Engineered T Cells Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Engineered T Cells by Region (2013-2018)
Figure Global Engineered T Cells Revenue Market Share by Region in 2017
Table Global Engineered T Cells Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Engineered T Cells Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Engineered T Cells by Application (2013-2018)
Figure Global Engineered T Cells Sales Market Share by Application (2013-2018)
Figure United States Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)
Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)
Table United States Engineered T Cells Sales Volume (K Units) by Players (2013-2018)
Table United States Engineered T Cells Sales Volume Market Share by Players (2013-2018)
Figure United States Engineered T Cells Sales Volume Market Share by Players in 2017
Table United States Engineered T Cells Sales Volume (K Units) by Type (2013-2018)
Table United States Engineered T Cells Sales Volume Market Share by Type (2013-2018)
Figure United States Engineered T Cells Sales Volume Market Share by Type in 2017
Table United States Engineered T Cells Sales Volume (K Units) by Application (2013-2018)
Table United States Engineered T Cells Sales Volume Market Share by Application (2013-2018)
Figure United States Engineered T Cells Sales Volume Market Share by Application in 2017
Figure Europe Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Engineered T Cells Sales Volume (K Units) by Players (2013-2018)
Table Europe Engineered T Cells Sales Volume Market Share by Players (2013-2018)
Figure Europe Engineered T Cells Sales Volume Market Share by Players in 2017
Table Europe Engineered T Cells Sales Volume (K Units) by Type (2013-2018)
Table Europe Engineered T Cells Sales Volume Market Share by Type (2013-2018)
Figure Europe Engineered T Cells Sales Volume Market Share by Type in 2017
Table Europe Engineered T Cells Sales Volume (K Units) by Application (2013-2018)
Table Europe Engineered T Cells Sales Volume Market Share by Application (2013-2018)
Figure Europe Engineered T Cells Sales Volume Market Share by Application in 2017
Figure China Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)
Figure China Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)
Table China Engineered T Cells Sales Volume (K Units) by Players (2013-2018)
Table China Engineered T Cells Sales Volume Market Share by Players (2013-2018)
Figure China Engineered T Cells Sales Volume Market Share by Players in 2017
Table China Engineered T Cells Sales Volume (K Units) by Type (2013-2018)
Table China Engineered T Cells Sales Volume Market Share by Type (2013-2018)
Figure China Engineered T Cells Sales Volume Market Share by Type in 2017
Table China Engineered T Cells Sales Volume (K Units) by Application (2013-2018)
Table China Engineered T Cells Sales Volume Market Share by Application (2013-2018)
Figure China Engineered T Cells Sales Volume Market Share by Application in 2017
Figure Japan Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Engineered T Cells Sales Volume (K Units) by Players (2013-2018)
Table Japan Engineered T Cells Sales Volume Market Share by Players (2013-2018)
Figure Japan Engineered T Cells Sales Volume Market Share by Players in 2017
Table Japan Engineered T Cells Sales Volume (K Units) by Type (2013-2018)
Table Japan Engineered T Cells Sales Volume Market Share by Type (2013-2018)
Figure Japan Engineered T Cells Sales Volume Market Share by Type in 2017
Table Japan Engineered T Cells Sales Volume (K Units) by Application (2013-2018)
Table Japan Engineered T Cells Sales Volume Market Share by Application (2013-2018)
Figure Japan Engineered T Cells Sales Volume Market Share by Application in 2017
Figure Southeast Asia Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Engineered T Cells Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Engineered T Cells Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Engineered T Cells Sales Volume Market Share by Players in 2017
Table Southeast Asia Engineered T Cells Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Engineered T Cells Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Engineered T Cells Sales Volume Market Share by Type in 2017
Table Southeast Asia Engineered T Cells Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Engineered T Cells Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Engineered T Cells Sales Volume Market Share by Application in 2017
Figure India Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)
Figure India Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)
Table India Engineered T Cells Sales Volume (K Units) by Players (2013-2018)
Table India Engineered T Cells Sales Volume Market Share by Players (2013-2018)
Figure India Engineered T Cells Sales Volume Market Share by Players in 2017
Table India Engineered T Cells Sales Volume (K Units) by Type (2013-2018)
Table India Engineered T Cells Sales Volume Market Share by Type (2013-2018)
Figure India Engineered T Cells Sales Volume Market Share by Type in 2017
Table India Engineered T Cells Sales Volume (K Units) by Application (2013-2018)
Table India Engineered T Cells Sales Volume Market Share by Application (2013-2018)
Figure India Engineered T Cells Sales Volume Market Share by Application in 2017
Table Autolus Limited Basic Information List
Table Autolus Limited Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Autolus Limited Engineered T Cells Sales Growth Rate (2013-2018)
Figure Autolus Limited Engineered T Cells Sales Global Market Share (2013-2018)
Figure Autolus Limited Engineered T Cells Revenue Global Market Share (2013-2018)
Table Bellicum Pharmaceuticals Basic Information List
Table Bellicum Pharmaceuticals Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bellicum Pharmaceuticals Engineered T Cells Sales Growth Rate (2013-2018)
Figure Bellicum Pharmaceuticals Engineered T Cells Sales Global Market Share (2013-2018)
Figure Bellicum Pharmaceuticals Engineered T Cells Revenue Global Market Share (2013-2018)
Table Cells Medica Basic Information List
Table Cells Medica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cells Medica Engineered T Cells Sales Growth Rate (2013-2018)
Figure Cells Medica Engineered T Cells Sales Global Market Share (2013-2018
Figure Cells Medica Engineered T Cells Revenue Global Market Share (2013-2018)
Table Elli Lilly and Company Basic Information List
Table Elli Lilly and Company Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Elli Lilly and Company Engineered T Cells Sales Growth Rate (2013-2018)
Figure Elli Lilly and Company Engineered T Cells Sales Global Market Share (2013-2018)
Figure Elli Lilly and Company Engineered T Cells Revenue Global Market Share (2013-2018)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Sciences Engineered T Cells Sales Growth Rate (2013-2018)
Figure Gilead Sciences Engineered T Cells Sales Global Market Share (2013-2018)
Figure Gilead Sciences Engineered T Cells Revenue Global Market Share (2013-2018)
Table Juno Therapeutics Basic Information List
Table Juno Therapeutics Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Juno Therapeutics Engineered T Cells Sales Growth Rate (2013-2018)
Figure Juno Therapeutics Engineered T Cells Sales Global Market Share (2013-2018
Figure Juno Therapeutics Engineered T Cells Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Engineered T Cells Sales Growth Rate (2013-2018)
Figure Novartis Engineered T Cells Sales Global Market Share (2013-2018)
Figure Novartis Engineered T Cells Revenue Global Market Share (2013-2018)
Table Oxford Biomedica Basic Information List
Table Oxford Biomedica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Oxford Biomedica Engineered T Cells Sales Growth Rate (2013-2018)
Figure Oxford Biomedica Engineered T Cells Sales Global Market Share (2013-2018
Figure Oxford Biomedica Engineered T Cells Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Engineered T Cells Sales Growth Rate (2013-2018)
Figure Pfizer Engineered T Cells Sales Global Market Share (2013-2018)
Figure Pfizer Engineered T Cells Revenue Global Market Share (2013-2018)
Table Precision Bioscience Basic Information List
Table Precision Bioscience Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Precision Bioscience Engineered T Cells Sales Growth Rate (2013-2018)
Figure Precision Bioscience Engineered T Cells Sales Global Market Share (2013-2018)
Figure Precision Bioscience Engineered T Cells Revenue Global Market Share (2013-2018)
Table Redmile Group Basic Information List
Table Seeking Alpha Basic Information List
Table Unum Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Engineered T Cells
Figure Manufacturing Process Analysis of Engineered T Cells
Figure Engineered T Cells Industrial Chain Analysis
Table Raw Materials Sources of Engineered T Cells Major Players in 2017
Table Major Buyers of Engineered T Cells
Table Distributors/Traders List
Figure Global Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Engineered T Cells Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Engineered T Cells Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Engineered T Cells Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Engineered T Cells Sales Volume Market Share Forecast by Regions in 2025
Table Global Engineered T Cells Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Engineered T Cells Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Engineered T Cells Revenue Market Share Forecast by Regions in 2025
Figure United States Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Engineered T Cells Revenue and Growth Rate Forecast (2018-2025)
Figure China Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Engineered T Cells Sales (K Units) Forecast by Type (2018-2025)
Figure Global Engineered T Cells Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Engineered T Cells Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Engineered T Cells Revenue Market Share Forecast by Type (2018-2025)
Table Global Engineered T Cells Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Engineered T Cells Sales (K Units) Forecast by Application (2018-2025)
Figure Global Engineered T Cells Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *